244 related articles for article (PubMed ID: 28173143)
1. Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4.
Eidahl JO; Giesige CR; Domire JS; Wallace LM; Fowler AM; Guckes SM; Garwick-Coppens SE; Labhart P; Harper SQ
Hum Mol Genet; 2016 Oct; 25(20):4577-4589. PubMed ID: 28173143
[TBL] [Abstract][Full Text] [Related]
2. p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.
Grow EJ; Weaver BD; Smith CM; Guo J; Stein P; Shadle SC; Hendrickson PG; Johnson NE; Butterfield RJ; Menafra R; Kloet SL; van der Maarel SM; Williams CJ; Cairns BR
Nat Genet; 2021 Aug; 53(8):1207-1220. PubMed ID: 34267371
[TBL] [Abstract][Full Text] [Related]
3. Conservation and innovation in the DUX4-family gene network.
Whiddon JL; Langford AT; Wong CJ; Zhong JW; Tapscott SJ
Nat Genet; 2017 Jun; 49(6):935-940. PubMed ID: 28459454
[TBL] [Abstract][Full Text] [Related]
4. Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.
Haynes P; Bomsztyk K; Miller DG
Epigenetics Chromatin; 2018 Aug; 11(1):47. PubMed ID: 30122154
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
Haynes P; Kernan K; Zhou SL; Miller DG
Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
[TBL] [Abstract][Full Text] [Related]
6. Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.
Wong CJ; Whiddon JL; Langford AT; Belleville AE; Tapscott SJ
Hum Mol Genet; 2022 May; 31(10):1694-1704. PubMed ID: 34888646
[TBL] [Abstract][Full Text] [Related]
7. Evolution of DUX gene macrosatellites in placental mammals.
Leidenroth A; Clapp J; Mitchell LM; Coneyworth D; Dearden FL; Iannuzzi L; Hewitt JE
Chromosoma; 2012 Oct; 121(5):489-97. PubMed ID: 22903800
[TBL] [Abstract][Full Text] [Related]
8. DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis.
Young JM; Whiddon JL; Yao Z; Kasinathan B; Snider L; Geng LN; Balog J; Tawil R; van der Maarel SM; Tapscott SJ
PLoS Genet; 2013 Nov; 9(11):e1003947. PubMed ID: 24278031
[TBL] [Abstract][Full Text] [Related]
9. Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice.
Bouwman LF; den Hamer B; Verveer EP; Lerink LJS; Krom YD; van der Maarel SM; de Greef JC
Skelet Muscle; 2020 Oct; 10(1):27. PubMed ID: 33004076
[TBL] [Abstract][Full Text] [Related]
10. Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.
Ansseau E; Eidahl JO; Lancelot C; Tassin A; Matteotti C; Yip C; Liu J; Leroy B; Hubeau C; Gerbaux C; Cloet S; Wauters A; Zorbo S; Meyer P; Pirson I; Laoudj-Chenivesse D; Wattiez R; Harper SQ; Belayew A; Coppée F
PLoS One; 2016; 11(1):e0146893. PubMed ID: 26816005
[TBL] [Abstract][Full Text] [Related]
11. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.
Jagannathan S; Shadle SC; Resnick R; Snider L; Tawil RN; van der Maarel SM; Bradley RK; Tapscott SJ
Hum Mol Genet; 2016 Oct; 25(20):4419-4431. PubMed ID: 28171552
[TBL] [Abstract][Full Text] [Related]
12. β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.
Banerji CR; Knopp P; Moyle LA; Severini S; Orrell RW; Teschendorff AE; Zammit PS
J R Soc Interface; 2015 Jan; 12(102):20140797. PubMed ID: 25551153
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy.
Clapp J; Mitchell LM; Bolland DJ; Fantes J; Corcoran AE; Scotting PJ; Armour JA; Hewitt JE
Am J Hum Genet; 2007 Aug; 81(2):264-79. PubMed ID: 17668377
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.
Block GJ; Petek LM; Narayanan D; Amell AM; Moore JM; Rabaia NA; Tyler A; van der Maarel SM; Tawil R; Filippova GN; Miller DG
PLoS One; 2012; 7(4):e35532. PubMed ID: 22536400
[TBL] [Abstract][Full Text] [Related]
15. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
Gatica LV; Rosa AL
Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
[TBL] [Abstract][Full Text] [Related]
16. Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein.
Bosnakovski D; Toso EA; Ener ET; Gearhart MD; Yin L; Lüttmann FF; Magli A; Shi K; Kim J; Aihara H; Kyba M
bioRxiv; 2023 Jan; ():. PubMed ID: 36711898
[TBL] [Abstract][Full Text] [Related]
17. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
Oliva J; Galasinski S; Richey A; Campbell AE; Meyers MJ; Modi N; Zhong JW; Tawil R; Tapscott SJ; Sverdrup FM
J Pharmacol Exp Ther; 2019 Aug; 370(2):219-230. PubMed ID: 31189728
[TBL] [Abstract][Full Text] [Related]
18. A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death.
Bosnakovski D; da Silva MT; Sunny ST; Ener ET; Toso EA; Yuan C; Cui Z; Walters MA; Jadhav A; Kyba M
Sci Adv; 2019 Sep; 5(9):eaaw7781. PubMed ID: 31535023
[TBL] [Abstract][Full Text] [Related]
19. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.
Bou Saada Y; Dib C; Dmitriev P; Hamade A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
Histochem Cell Biol; 2016 Apr; 145(4):475-83. PubMed ID: 26860865
[TBL] [Abstract][Full Text] [Related]
20. p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy.
Bosnakovski D; Gearhart MD; Toso EA; Recht OO; Cucak A; Jain AK; Barton MC; Kyba M
Dis Model Mech; 2017 Oct; 10(10):1211-1216. PubMed ID: 28754837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
